Kristina Burow

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Chicago, IL
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Junlin Ho, attorney-in-fact for Kristina Burow
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Kristina Burow

Form 4 holding Director

Beam Therapeutics Inc.

Security class
Common Stock
Shares / value
2,721,519
Estimated value
$71,902,532
Report date
06 Jun 2023
Price
$26.42
Ownership
Indirect
Form 4 holding Director

Beam Therapeutics Inc.

Security class
Common Stock
Shares / value
26,011
Estimated value
$687,211
Report date
06 Jun 2023
Price
$26.42
Ownership
Direct
Form 4 holding Director

Beam Therapeutics Inc.

Security class
Stock Option (Right to Buy)
Shares / value
16,532
Estimated value
$403,381
Report date
06 Jun 2023
Price
$24.40
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Gossamer Bio, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
35,000
Estimated value
Report date
08 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Unity Biotechnology, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
25,000
Estimated value
Report date
24 Jun 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Metacrine, Inc.

Security class
Stock Option (right to buy)
Shares / value
16,500
Estimated value
Report date
24 May 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Boundless Bio, Inc.

Security class
Stock Option (right to buy)
Shares / value
16,000
Estimated value
Report date
23 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Metsera, Inc.

Security class
Restricted Stock Unit
Shares / value
2,688
Estimated value
Report date
13 Nov 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Metsera, Inc.

Security class
Series A Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
03 Feb 2025
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Metsera, Inc.

Security class
Series B Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
03 Feb 2025
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Metsera, Inc.

Security class
Series Seed Preferred Stock
Shares / value
0
Estimated value
Report date
03 Feb 2025
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Metsera, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
13 Nov 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Kristina Burow

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .